|


 |
The RCMI Program at Ponce School of Medicine was established in 1985. It has transformed
PSM from a teaching medical school to a vigorous Research Center. Recently acquired state-of-
the-art instrumentation has vastly expanded the scope of current research activities as well as
stimulating both faculty and student research development. Several new research faculty
members have been recruited and their contributions have enabled us to further expand the scope
of our research. Currently, Research programs at PSM include: AIDS Research Program,
neuroscience, human genetic, asthma research, cancer research, alcohol/drug-related research,
toxicology, and the reproductive sciences, to name but a few.
Moreover, infrastructure support from the RCMI Program was crucial to the development of the
graduate PhD program in Biomedical Sciences, which became fully accredited by the Council of
Higher Education of Puerto Rico in May of 1992.
|
|
|
Background
The Research Centers in Minority Institutions (RCMI) Program in the Division of Research
Infrastructure at the National Center for Research Resources (NCRR) is a congressionally mandated
program initiated by the National Institutes of Health (NIH) in 1985. The authorizing legislation for the
program highlighted the findings of the annual report from the Department of Health and Human
Services Secretary’s Task Force on the health status of the American people and noted major health
disparities between minority and majority Americans.The legislation alsoacknowledged the important
role that minority educational institutions have traditionally played in training professionals who then go
on to provide health care to the minority community. Implicit in the legislative language is the major role
that minority institutions must play in order for the NIH to address the health needs of the entire US
population. It is believed that this mandate can be achieved by enhancing the research capacities of
RCMI-eligible institutions so that they might better conduct state-of-the-art biomedical and/or
behavioral research.
The RCMI Program provides, on a competitive basis, a wide array of support to eligible
institutions that assists them in developing their biomedical research infrastructure. This has
enabled them to contribute to the knowledge base that is needed to address the causes, the
effects, and the prevention of human suffering.
Currently, 18 institutions are recipients of grants through the RCMI Program. Included among
them are seven medical schools, three pharmaceutical colleges, seven graduate schools, and one
school of veterinary medicine; they are located in Florida, Alabama, Georgia, Louisiana,
New York, Hawaii, Tennessee, California, Texas, Puerto Rico, and the District of Columbia.
In addition to providing direct support to enhance institutional research infrastructures, the
RCMI Program continues to develop other mechanisms for pursuing new and innovative ways to
increase opportunities for faculty at RCMI grantee institutions to interact with key staff,
collaborate with investigators supported by other NIH components and PHS agencies, and to join
with the biomedical research community to push back the frontier of biomedicine. Through the
enhancement of the biomedical and/or behavioral research capacity of eligible institutions, the
RCMI Program mandate is being achieved.
Back to Top |
|
|
Goals & Objectives
The Research Centers in Minority Institutions (RCMI) Program was initiated in order to enhance
the research capacity and infrastructure at minority colleges and universities that offer doctorates
in health sciences. Graduate institutions eligible to apply for the RCMI grants must have one or
more underrepresented minority groups that comprise 50 percent or greater of their student body
representation and offer doctorate degrees in the health-related sciences.
RCMI support is provided by the NCRR Division of Research Infrastructure (DRI) and is used,
in part, to recruit established and promising researchers, acquire advanced instrumentation,
modify laboratories for competitive research, fund core research facilities, and support other
research efforts. Because many investigators at RCMI institutions study diseases that
disproportionately affect minorities, NCRR assistance is intended to serve the dual purposes of
bringing more minority scientists into mainstream research and enhancing studies of minority
health.
The DRI also funds the RCMI Clinical Research Infrastructure Initiative. This initiative supports
clinical research activities at institutions that have RCMIs to encourage minority scientists to
participate in clinical investigations.
|
|